I believe that they are gearing up for a full marketing Blitz.
Lonza:
"As one of the frontrunners in the contract manufacture of monoclonal antibodies and recombinant proteins from mammalian cell culture, Lonza produces the essential ingredients for tomorrow’s life-saving medicines with four state-of-the-art cGMP multi-product facilities. One of these facilities is in the UK in the Thames Valley technology corridor, which focuses on process development and clinical trial supply (including small-scale manufacture of licensed products). The second is in the USA, just outside Boston, Massachusetts, focusing on large-scale manufacture for late-stage clinical trials and in-market supply. The third is in Northern Spain, and the fourth is currently under construction in Singapore. We are hard at work developing the world’s most advanced biotechnology manufacturing processes."
"Lonza is the world's leading contract manufacturer of monoclonal antibodies and recombinant proteins. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries based on more than 25 years of experience in mammalian cell culture and proprietary technology for large-scale manufacture of innovative biopharmaceutical products"
Source:http://www.lonza.com/group/en/products_services/custommanufactoring/mammalian.html
Now all we have to wait for is the FDA Approval. As far as I know,Ipilimumab has not been submitted to the FDA for approval at this time.
Take Care,
Jimmy B
No comments:
Post a Comment